| 产品详情 |
| Edit |   |
|---|
| Product Name | Glucagon-Like Peptide 1 Receptor Agonist II |
|---|
| Description | Purity ~95% (HPLC). A pyrimidine small molecule that acts as a GLP-1 allosteric agonist that induces cAMP signaling in HEK293 cells expressing the GLP-1 receptor with EC50 = 0.66uM and 99% efficacy (similar data with rat GLP-1 receptor), does not compete with radiolabelled GLP-1 in receptor binding assays, and is not active in cells expressing the GLP-2, GIP, PTH, or glucagon receptors. In rodent islets, insulin secretion increases in a dose-dependent and glucose-dependent manner, either alone or in an additive fashion when combined with the endogenous GLP-1 peptide. In vivo, this molecule exhibits insulinotropic effects when dosed at 10mg/kg in SD rats undergoing an IVGTT and a hyperglycemic clamp. It is also shown to increase insulin secretion in perifusion assays involving normal and diabetic human islets ex vivo, at concentrations between 1 and 10uM. Formula: C20H17F3N2O2S Solubility: DMSO (100mg/ml) Molecular Weight: 406.42 |
|---|
| Size | 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Glucagon-Like Peptide 1 Receptor Agonist II (4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine, Glucagon-Like Peptide 1 Receptor Agonist II, Compound B) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 217386 |
|---|
| Price | |
|---|
| Order / More Info | Glucagon-Like Peptide 1 Receptor Agonist II from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|